Advanced Medical Solutions Group plc Stock

Equities

AMS

GB0004536594

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:17 2024-05-28 am EDT 5-day change 1st Jan Change
216.5 GBX +1.64% Intraday chart for Advanced Medical Solutions Group plc +1.64% +4.34%
Sales 2024 * 179M 228M Sales 2025 * 232M 297M Capitalization 463M 591M
Net income 2024 * 9M 11.49M Net income 2025 * 17M 21.71M EV / Sales 2024 * 2.7 x
Net Debt 2024 * 19.75M 25.22M Net Debt 2025 * 14.3M 18.26M EV / Sales 2025 * 2.05 x
P/E ratio 2024 *
46.4 x
P/E ratio 2025 *
26 x
Employees 850
Yield 2024 *
1.19%
Yield 2025 *
1.37%
Free-Float 97.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.38%
1 week+1.38%
Current month+14.01%
1 month+14.25%
3 months+5.08%
6 months+3.07%
Current year+4.06%
More quotes
1 week
207.00
Extreme 207
215.93
1 month
185.20
Extreme 185.2
218.17
Current year
176.60
Extreme 176.6
220.00
1 year
165.60
Extreme 165.6
261.00
3 years
165.60
Extreme 165.6
347.00
5 years
165.60
Extreme 165.6
356.50
10 years
106.85
Extreme 106.8545
374.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 05-06-30
Director of Finance/CFO 52 11-10-04
Chief Tech/Sci/R&D Officer - 01-12-31
Members of the board TitleAgeSince
Director/Board Member 66 21-01-31
Chief Executive Officer 57 05-06-30
Director/Board Member 58 21-08-01
More insiders
Date Price Change Volume
24-05-28 216.5 +1.64% 287 117
24-05-24 213 +0.95% 233,588
24-05-23 211 -0.47% 203,097
24-05-22 212 -0.47% 304,489
24-05-21 213 0.00% 413,651

Delayed Quote London S.E., May 28, 2024 at 05:01 am EDT

More quotes
Advanced Medical Solutions Group plc is a United Kingdom-based developer and manufacturer of tissue-healing technology, focused on quality outcomes for patients. The Company offers a range of surgical products, including tissue adhesives, sutures, haemostats, internal fixation devices, bone substitutes and internal sealants, which it markets under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIXTM and SEAL-G brands. The Company also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal brand as well as under white label. Its Surgical Business Unit includes tissue adhesives, sutures, biosurgical devices and internal fixation devices. The Woundcare Business Unit is comprised of multi-product portfolio of advanced wound care dressings and a portfolio of specialist medical bulk materials and multi-layer wound care products. Its products are manufactured in the United Kingdom, Germany, France, the Netherlands, the Czech Republic and Israel.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
2.13 GBP
Average target price
2.58 GBP
Spread / Average Target
+21.13%
Consensus